Medicare Enrolled
Dr. An Pham, MD
Pulmonary Disease · Pottstown, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pham?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pham
Dr. An Pham is a pulmonary disease specialist in Pottstown, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pham performed 36,655 Medicare services across 3,472 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pham received a total of $28,688 from 53 pharmaceutical and/or device companies across 1498 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pham is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in PA
$28,688 industry payments
Medicare Practice Summary
Medicare Utilization ↗36,655
Medicare services
Top 0% in PA for pulmonary disease
3,472
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,833 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, mepolizumab, 1 mg | 18,434 | $23 | $42 |
| Omalizumab injection (Xolair) for asthma/allergy | 10,944 | $30 | $46 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,671 | $67 | $147 |
| Injection, benralizumab, 1 mg | 1,292 | $132 | $200 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,071 | $11 | $50 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
835 | $21 | $49 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
530 | $97 | $208 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
480 | $34 | $72 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
472 | $46 | $98 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
280 | $9 | $20 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
140 | $509 | $2,753 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
116 | $126 | $270 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
102 | $488 | $3,169 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
83 | $29 | $30 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
81 | $72 | $90 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
58 | $27 | $54 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
55 | $118 | $751 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $86 | $181 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$28,688
Total received (2018-2024)
Avg $4,098/year across 7 years
Top 10% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
1,498
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,646 (96.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$842 (2.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$200 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,063
2023
$5,124
2022
$4,779
2021
$4,268
2020
$2,795
2019
$3,163
2018
$2,496
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,191
GENZYME CORPORATION
$582
GlaxoSmithKline, LLC.
$570
Actelion Pharmaceuticals US, Inc.
$534
Regeneron Healthcare Solutions, Inc.
$349
JAZZ PHARMACEUTICALS INC.
$288
Mallinckrodt Hospital Products Inc.
$280
Mylan Specialty L.P.
$275
Avadel CNS Pharmaceuticals, LLC
$256
Philips North America LLC
$245
Bayer Healthcare Pharmaceuticals Inc.
$200
Axsome Therapeutics, Inc.
$174
HARMONY BIOSCIENCES LLC
$164
United Therapeutics Corporation
$162
PFIZER INC.
$159
Amgen Inc.
$90
SANOFI-AVENTIS U.S. LLC
$89
Electromed, Inc.
$89
Novartis Pharmaceuticals Corporation
$76
Genentech USA, Inc.
$69
Harmony Biosciences Llc
$64
Grifols USA, LLC
$44
Insmed, Inc.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$30
Baxter Healthcare
$28
Inspire Medical Systems, Inc.
$21
Top 3 companies account for 38.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$4,741
GlaxoSmithKline, LLC.
$3,165
Actelion Pharmaceuticals US, Inc.
$2,463
GENZYME CORPORATION
$1,824
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,637
Regeneron Healthcare Solutions, Inc.
$1,510
JAZZ PHARMACEUTICALS INC.
$1,213
Mylan Specialty L.P.
$1,032
United Therapeutics Corporation
$802
Mallinckrodt Hospital Products Inc.
$798
Philips Electronics North America Corporation
$774
PFIZER INC.
$770
Novartis Pharmaceuticals Corporation
$725
Insmed, Inc.
$708
Genentech USA, Inc.
$605
HARMONY BIOSCIENCES LLC
$528
Advanced Respiratory, Inc
$492
Sunovion Pharmaceuticals Inc.
$451
Harmony Biosciences LLC
$410
Axsome Therapeutics, Inc.
$358
Teva Pharmaceuticals USA, Inc.
$310
Amgen Inc.
$307
Avadel CNS Pharmaceuticals, LLC
$273
Baxter Healthcare
$258
Philips North America LLC
$245
Jazz Pharmaceuticals Inc.
$231
SANOFI-AVENTIS U.S. LLC
$219
Bayer Healthcare Pharmaceuticals Inc.
$200
Mallinckrodt LLC
$187
Grifols USA, LLC
$172
Electromed, Inc.
$164
Merck Sharp & Dohme LLC
$157
Mallinckrodt Enterprises LLC
$136
Takeda Pharmaceuticals U.S.A., Inc.
$119
Shire North American Group Inc
$80
Shionogi Inc
$65
ANI Pharmaceuticals, Inc.
$64
Harmony Biosciences Llc
$64
Circassia Pharmaceuticals Inc
$56
Alexion Pharmaceuticals, Inc.
$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$47
Janssen Pharmaceuticals, Inc
$39
Aytu BioScience, Inc
$39
Inspire Medical Systems, Inc.
$34
Inogen, Inc.
$27
Paratek Pharmaceuticals, Inc.
$22
Merck Sharp & Dohme Corporation
$22
Eisai Inc.
$18
Resmed Corp
$17
IDORSIA PHARMACEUTICALS US INC
$17
Exeltis, USA Inc.
$17
Abbott Laboratories
$16
Nabriva Therapeutics, plc
$11
Top 3 companies account for 36.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · Adempas · AirDuo Digihaler · Alere i · Arikayce · Astral · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CINQAIR · CUTAQUIG · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · ELIQUIS · ERWINAZE · Esbriet · FARXIGA · FASENRA · GLASSIA · HYQVIA · Hillrom - Carnation Ambulatory Monitor · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · InogenOne · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · Mulpleta · NIOX VERO · NUCALA · NUZYRA · Natesto · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · QVAR · Respiratoriy Care Undiv · S&RC Und · SMARTVEST · SOLIRIS · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The MetaNeb System · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · Trilogy 100 · Tuzistra XR · UPTRAVI · UTIBRON NEOHALER · Utibron · Volara System · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XIFAXAN · XIFAXANIBSD · XOLAIR · XYREM · XYWAV · Xembify · Xenleta · Xolair · Xyrem · YUPELRI · Yupelri · ZolpiMist · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for pulmonary disease in PA.
Geographic Context
Pulmonary diseases within 10 mi
57
Per 100K population
6.6
County median income
$111,521
Nearest hospital
POTTSTOWN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pham is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with low-engagement industry engagement in the top 10% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pham experienced with injection, mepolizumab, 1 mg?
Based on Medicare claims data, Dr. Pham performed 18,434 injection, mepolizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pham receive payments from pharmaceutical companies?
Yes. Dr. Pham received a total of $28,688 from 53 companies across 1,498 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pham's costs compare to other pulmonary diseases in Pottstown?
Dr. Pham's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Pottstown
Browse pulmonary diseases in Pottstown ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in PA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in PA
Which PA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology